The use of inhibitors of bruton’s tyrosine kinase (btk)

• 收藏
• 分享

专利权人:

Pharmacyclics LLC

发明人:

Buggy, Joseph,Elias, Laurence,Fyfe, Gwen,Hedrick, Eric,Loury, David,Mody, Tarak

申请号：

NZ75302411

公开号：

NZ753024A

申请日:

2011.06.03

申请国别(地区):

NZ

年份:

2020

代理人:

摘要：

Disclosed is the use of (R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one (ibrutinib / PCI-32765) in the manufacture of a medicament for treating diffuse large B-cell lymphoma (DLBCL) in an individual in need thereof, wherein the medicament is formulated for administration of the compound once per day in an amount of about 560 mg, in a solid oral dosage form.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/